Mohammad Azab
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 14
- Acute Myeloid Leukemia Research 13
-
- Histone Deacetylase Inhibitors Research 5
- Epigenetics and DNA Methylation 5
- Co-authors
- Aram Oganesian (9 shared papers)Elizabeth A. Griffiths (8 shared papers)Gail J. Roboz (8 shared papers)Hagop M. Kantarjian (10 shared papers)Karen Yee (6 shared papers)Casey L. O’Connell (7 shared papers)Yong Hao (4 shared papers)Pietro Taverna (7 shared papers)
- Journals
- Blood (7 papers)Cancer Chemotherapy and Pharmacology (2 papers)Cancer (1 paper)World Neurosurgery (1 paper)Future Oncology (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Mohammad Azab
18 papers receiving 537 citations
Peers
Comparison fields: 5 of 58
- Hematology 309
- Genetics 87
- Molecular Biology 367
- Cancer Research 36
- Public Health, Environmental and Occupational Health 69
Countries citing papers authored by Mohammad Azab
This map shows the geographic impact of Mohammad Azab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Azab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Azab more than expected).
Fields of papers citing papers by Mohammad Azab
This network shows the impact of papers produced by Mohammad Azab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Azab. The network helps show where Mohammad Azab may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohammad Azab, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 210 | |
| 2 | 2020 | 145 | |
| 3 | 2017 | 49 | |
| 4 | 2014 | 25 | |
| 5 | 2023 | 22 | |
| 6 | 2020 | 15 | |
| 7 | 2021 | 15 | |
| 8 | 2016 | 13 | |
| 9 | 2023 | 12 | |
| 10 | 2016 | 10 | |
| 11 | 2022 | 8 | |
| 12 | 2012 | 6 | |
| 13 | 2015 | 4 | |
| 14 | 2010 | 3 | |
| 15 | 2015 | 3 | |
| 16 | 2014 | 1 | |
| 17 | 2015 | 1 | |
| 18 | 2018 | 1 | |
| 19 | 2019 | 0 |
About Mohammad Azab
Mohammad Azab is a scholar working on Hematology, Molecular Biology, Public Health, Environmental and Occupational Health, Genetics and Oncology, having authored 19 papers that have together received 543 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (13 papers), Histone Deacetylase Inhibitors Research (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Epigenetics and DNA Methylation (5 papers), Chronic Lymphocytic Leukemia Research (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Cancer Genomics and Diagnostics (2 papers) and Neutropenia and Cancer Infections (2 papers). The work is most often cited by research in Hematology (309 citations), Genetics (87 citations), Molecular Biology (367 citations), Cancer Research (36 citations) and Public Health, Environmental and Occupational Health (69 citations). Mohammad Azab has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Aram Oganesian, Elizabeth A. Griffiths, Gail J. Roboz, Hagop M. Kantarjian, Karen Yee, Casey L. O’Connell, Yong Hao, Pietro Taverna, David A. Rizzieri and Katherine Walsh. Their work appears in journals such as Blood, Cancer Chemotherapy and Pharmacology, Cancer, World Neurosurgery and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.